| {"0": "Nonalcoholic fatty liver disease", "1": "Electron transport chain oxphos system in mitochondria", "2": "Cholesterol metabolism with bloch and kandutschrussell pathways", "3": "Mitochondrial complex iv assembly", "4": "Overlap between signal transduction pathways contributing to lmna laminopathies", "5": "Mitochondrial complex i assembly model oxphos system", "6": "Ferroptosis", "7": "Familial partial lipodystrophy fpld", "8": "Glycosaminoglycan degradation", "9": "Cholesterol biosynthesis pathway", "10": "Degradation pathway of sphingolipids including diseases", "11": "Oxidative phosphorylation", "12": "Vitamin d receptor pathway", "13": "Allograft rejection", "14": "Mecp2 and associated rett syndrome", "15": "Thermogenesis", "16": "Circadian rhythm genes", "17": "Ppar signaling pathway", "18": "Metapathway biotransformation phase i and ii", "19": "Energy metabolism", "20": "Calcium regulation in cardiac cells", "21": "Fatty acid betaoxidation", "22": "Alzheimers disease and mirna effects", "23": "Alzheimers disease", "24": "Ciliary landscape", "25": "Angiopoietinlike protein 8 regulatory pathway", "26": "Regucalcin in proximal tubule epithelial kidney cells", "27": "Il18 signaling pathway", "28": "Egfegfr signaling pathway", "29": "Photodynamic therapyinduced ap1 survival signaling", "30": "Tnfrelated weak inducer of apoptosis tweak signaling pathway", "31": "Prion disease pathway", "32": "Proteasome degradation"} |